Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Lalgarh shows why Naxalism is growing
The road to Lalgarh, in the heart of West Bengal’s Naxal badlands, is now secure. But it is still a distance too far for many of the districts" administrators to travel.

3G auction as per scheduled on Jan 14
The government today said auction for 3G mobile spectrum would commence as per schedule from January 14 next year and allotment would be made to four private players simultaneously by August 2010.

News of the day

PSUs' peculiar problem
With profit-making not being the sole motive of public units, caution needs to be exercised while investing in their IPOs.
Business Opportunities

Sun Pharma unit gets USFDA nod for anti-allergic drug

Drug firm Sun Pharma today said it has received the US regulator"s approval for the generic version of Acular, used to treat pain and swelling after eye surgeries. - Caraco looking at shifting production to India - Sun Pharma accuses Taro director of misusing funds - Sun Pharma net profit dips 11.5% - "We are not a topline-driven company" - Sun Pharma profit dips 11.49% - Bhupesh Bhandari: The new pharmaceutical order">Bhupesh Bhandari: The new pharmaceutical order The US Food and Drug Administrator (USFDA) has granted approval for the Abbreviated New Drug Application (ANDA) for the generic version of Acular, which is also known as Ketotrolac Tromethamine Opthalmic Solution, Sun Pharma said in a filing to the Bombay Stock Exchange. US-based drug firm Allergan Inc has patent rights over Ketotrolac Tromethamine Opthalmic Solution and the company is selling the drug under the brand Acular. The drug is indicated for the temporary relief of ocular itching due to seasonal allergic conductivities, it said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009